Can colchicine protect heart health in kidney disease?
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if a low-dose anti-inflammatory medication (colchicine) can help protect the heart and blood vessels in people with advanced kidney disease or on dialysis. It aims to lower inflammation that may increase heart risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced kidney disease (stage 4 or 5) or are on chronic dialysis for at least 3 months.
- You are 18 years or older.
- You are not allergic to colchicine and have not had bad side effects from it.
- You are not pregnant, planning pregnancy, or breastfeeding.
- You do not have serious liver disease, uncontrolled diarrhea, or certain blood issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether colchicine can reduce inflammation and improve heart function in people with kidney disease and a certain type of heart problem. If you qualify, you’ll be closely monitored for side effects and lab changes.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This trial tests if a low dose of colchicine, a medicine that reduces inflammation, can help improve blood vessel and bone health in people with moderate chronic kidney disease.
This trial tests whether taking colchicine can prevent coronary artery disease (heart artery blockages) in people who have several heart risk factors but do not already have diagnosed disease. It aims to see if colchicine lowers the chance of developing heart artery problems over time.
This trial tests if colchicine, an anti-inflammatory medicine, can help people with a type of heart failure where the heart pumps well but is stiff and inflamed. You may join if your heart failure recently worsened and you have signs of inflammation in your blood.
This study tests if colchicine, a medicine used for gout and inflammation, can help people with coronary heart disease who have had a stent placed. You might be eligible if you have ongoing inflammation (measured by a simple blood test) and are already on standard heart medications.
Hear when a new Renal Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.